cytarabine has been researched along with mannitol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (31.82) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flessner, T; Takayanagi, M; Wong, CH | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blau, HJ | 1 |
| Bories, J; Chiras, J; Fauchon, F; Guérin, RA; Poisson, M; Rose, M; Terrier, L | 1 |
| Jánossa, M; Kelemen, E; Magyar, T; Sellyei, M; Szalay, F; Triska, E; Váradi, A | 1 |
| Hunstein, W | 1 |
| Maurice, PA | 1 |
| Clifford, P; Klein, G; Singh, S; Stjernswärd, J | 1 |
| Gantt, R; Jones, GM; Parshad, R; Sanford, KK; Tarone, RE | 1 |
| Belanger, G; Benoit, B; DaSilva, V; Grahovac, Z; Hugenholtz, H; Richard, MT; Russell, N; Stewart, DJ | 1 |
| Akhurst, LC; Bertens, A; Botta, A; Cinelli, S; Clare, MG; Lorenzon, G; Lorge, E; Marzin, D; Montero, R; Thybaud, V; van Delft, J | 1 |
| Araki, H; Hamada, S; Itoh, S; Kobayashi, K; Kubo, K; Lorenzon, G; Lorge, E; Marzin, D; Matsui, A; Matsuoka, A; Miyajima, H; Nishida, S; Senjyu, N; Thybaud, V; Wakata, A; Yamakage, K; Yamamura, E; Yoshida, J | 1 |
| Aardema, MJ; Curry, PT; Divi, K; Gibson, DP; Lorenzon, G; Lorge, E; Marzin, D; Mauthe, RJ; Morita, T; Snyder, RD; Soelter, S; Spicer, C; Thybaud, V | 1 |
| Aardema, MJ; Lorenzon, G; Lorge, E; Marzin, D; Oliver, J; Thybaud, V; Wakata, A | 1 |
| Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
| Goldstein, DA; Tessler, HH | 1 |
| Fujisaki, T; Moriyama, Y; Muta, T; Sawada, Y; Seike, Y; Tokuyama, T; Ueda, Y | 1 |
| Chen, SJ; Chen, WL; Chen, Z; Cheng, Z; Jia, W; Liu, J; Ni, Y; Qu, C; Rajani, C; Su, M; Wang, YY; Wei, R; Xia, L; Xie, G; Zhao, A; Zhao, L | 1 |
2 review(s) available for cytarabine and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Therapeutic considerations in chronic myeloid leukemia].
Topics: Busulfan; Chronic Disease; Cytarabine; Humans; Hydrocarbons, Brominated; Leukemia, Myeloid; Mannitol | 1974 |
1 trial(s) available for cytarabine and mannitol
| Article | Year |
|---|---|
Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cytarabine; Female; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Mannitol; Middle Aged; Survival Rate; Teniposide | 1993 |
19 other study(ies) available for cytarabine and mannitol
| Article | Year |
|---|---|
A strategy for the solution-phase parallel synthesis of N-(pyrrolidinylmethyl)hydroxamic acids.
Topics: Fucosyltransferases; Guanosine Diphosphate Fucose; Hydroxamic Acids; Indicators and Reagents; Manganese; Mannitol; Molecular Conformation; Molecular Structure; Pyrrolidines; Solutions | 2000 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Side effects of cytostatic therapy in childhood].
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Fluorouracil; Humans; Male; Mannitol; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Time Factors; Triaziquone; Vinblastine; Vincristine | 1976 |
Intra-arterial chemotherapy by cisplatin and cytarabine after temporary disruption of the blood-brain barrier for the treatment of malignant gliomas in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Cisplatin; Cytarabine; Female; Glioma; Humans; Injections, Intra-Arterial; Male; Mannitol; Middle Aged | 1986 |
Bone marrow transplantation in accelerated chronic granulocytic leukaemia using dibromomannitol-preconditioning instead of total-body irradiation.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Humans; Leukemia, Myeloid; Male; Mannitol; Mitobronitol; Neutrophils; Premedication; Splenectomy; Whole-Body Irradiation | 1985 |
[Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Examination; Busulfan; Cytarabine; Female; Humans; Leukemia, Myeloid; Leukocytosis; Male; Mannitol; Mercaptopurine; Middle Aged; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Splenic Neoplasms; Splenomegaly; Vincristine | 1970 |
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Topics: Adolescent; Antineoplastic Agents; Burkitt Lymphoma; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Female; Humans; Immunotherapy; Infant; Kenya; Male; Mannitol; Melphalan; Methotrexate; Nitrogen Mustard Compounds; Nitroso Compounds; Urea | 1967 |
Repair of chromosome damage induced by X-irradiation during G2 phase in a line of normal human fibroblasts and its malignant derivative.
Topics: 4-Nitroquinoline-1-oxide; Caffeine; Catalase; Cell Line; Cell Transformation, Neoplastic; Chromosome Aberrations; Cytarabine; DNA Repair; Fibroblasts; Humans; Interphase; Mannitol; Radiation Dosage | 1982 |
SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes.
Topics: Adult; Aneugens; Bleomycin; Clofibrate; Colchicine; Cytarabine; Diethylstilbestrol; Female; Fluorouracil; Humans; In Vitro Techniques; International Cooperation; Lymphocytes; Male; Mannitol; Micronucleus Tests; Mutagens; Thiabendazole; Urethane | 2006 |
SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.
Topics: Aneugens; Animals; Bleomycin; Cell Line; Clofibrate; Colchicine; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; Fluorouracil; Griseofulvin; In Vitro Techniques; International Cooperation; Mannitol; Micronucleus Tests; Mutagens; Urethane | 2006 |
SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells.
Topics: Aneugens; Animals; Bleomycin; CHO Cells; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; In Vitro Techniques; International Cooperation; Mannitol; Micronucleus Tests; Mitomycin; Mutagens; Urethane | 2006 |
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
Topics: Aneugens; Animals; Bleomycin; Cell Line; CHO Cells; Clofibrate; Colchicine; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; Fluorouracil; Griseofulvin; Humans; In Vitro Techniques; International Cooperation; Leukemia L5178; Lymphocytes; Mannitol; Mice; Micronucleus Tests; Mitomycin; Mutagens; Thiabendazole | 2006 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
[Chronic myeloid leukemia complicated with cerebellar hemorrhage and acute hydrocephalus successfully treated with imatinib and intensive supportive care].
Topics: Acute Disease; Antineoplastic Agents; Benzamides; Cerebellum; Cerebral Hemorrhage; Combined Modality Therapy; Critical Care; Cytarabine; Drug Therapy, Combination; Female; Humans; Hydrocephalus; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukostasis; Mannitol; Middle Aged; Piperazines; Pyrimidines; Respiration, Artificial | 2010 |
Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.
Topics: Animals; Cell Line, Tumor; Cytarabine; Drug Synergism; Fructose; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose Transporter Type 5; Humans; Leukemia, Myeloid, Acute; Mannitol; Mice; Prognosis; Treatment Outcome; Up-Regulation | 2016 |